Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

2012 Vaccine Research Seminars

Future Seminars | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Tuesdays at 4 pm (except as noted): Building 40 (VRC), Room 1203





Jun 5 Chris Love Mass. Institute of Technology Integrated and dynamic single-cell analysis of human lymphocytes
May 29 Bart Haynes Duke Human Vaccine Institute B cell lineage vaccine design: Overcoming host factors for induction of broad neutralizing antibodies to HIV
May 22 Tim Schacker University of Minnesota HIV reservoirs, HAART and implications for virus eradication
May 15 Nick Haining Dana Farber Cancer Institute Molecular mechanisms of T cell exhaustion in humans
May 8 Mike Lenardo NIAID, NIH Molecular regulation of lymphocyte homeostasis
May 1 Rahul Kohli University of Pennsylvania Purposeful targeted mutation by AID/APOBEC cytosine deaminase as an immunologic weapon
Apr 24 Rick Blumberg Brigham and Women’s Hospital The immunological functions of the (not so) neonatal FcR for IgG
Apr 17 Gepi Pantaleo University of Lausanne T-cell immunity in HIV infection and vaccine development
Mar 6 Robin Shattock St. George's Hosp., Univ. London Vaginal antibodies as a determinant of HIV susceptibility
Feb 28 Pat Earl NIAID, NIH Small animal models for studying monkeypox virus pathogenesis
Feb 21 Ed Mocarski Emory University Caspase-8 and RIP3-dependent death pathways: lessons from Cytomegalovirus
Feb 14 Jim Crowe Vanderbilt University Genetic and structural complexity of human antibody repertoires
February 7, 2012 Fred Alt Harvard University High throughput analysis of mechanisms that influence chromosomal rearrangements and translocations in lymphocytes
January 31, 2012 Chris Walker Ohio State University Immune control of persistent hepatitis C virus infection
January 24, 2012 Jeff Cohen NIAID, NIH Herpes simplex virus 2 vaccines: Beyond glycoproteins

View Past Seminars

back to top

Last Updated March 07, 2012

Last Reviewed January 25, 2012